These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1321359)

  • 1. Inhibition of enkephalin metabolism and activation of mu- or delta-opioid receptors elicit opposite effects on reward and motility in the ventral mesencephalon.
    Heidbreder C; Gewiss M; Lallemand S; Roques BP; De Witte P
    Neuropharmacology; 1992 Mar; 31(3):293-8. PubMed ID: 1321359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.
    de Witte P; Heidbreder C; Roques BP
    Neuropharmacology; 1989 Jul; 28(7):667-76. PubMed ID: 2761678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.
    Calenco-Choukroun G; Daugé V; Gacel G; Féger J; Roques BP
    Psychopharmacology (Berl); 1991; 103(4):493-502. PubMed ID: 1648248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1988; 96(3):343-52. PubMed ID: 2851851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
    Calenco-Choukroun G; Daugé V; Gacel G; Roques BP
    Eur J Pharmacol; 1991 Dec; 209(3):267-71. PubMed ID: 1665799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward.
    Duvauchelle CL; Fleming SM; Kornetsky C
    Eur J Pharmacol; 1996 Dec; 316(2-3):137-43. PubMed ID: 8982679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
    Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP
    Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.
    Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F
    J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medial thalamic injection of opioid agonists: mu-agonist increases while kappa-agonist decreases stimulus thresholds for pain and reward.
    Carr KD; Bak TH
    Brain Res; 1988 Feb; 441(1-2):173-84. PubMed ID: 2833999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
    Meucci E; Delay-Goyet P; Roques BP; Zajac JM
    Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of mu- and delta-receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices.
    Lupica CR; Dunwiddie TV
    Synapse; 1991 Aug; 8(4):237-48. PubMed ID: 1656539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor autoradiography of mu and delta opioid peptide receptors in spontaneously hypertensive rats.
    Kujirai K; Fahn S; Cadet JL
    Peptides; 1991; 12(4):779-85. PubMed ID: 1664945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mu opioid agonist DAMGO alters the intravenous self-administration of cocaine in rats: mechanisms in the ventral tegmental area.
    Corrigall WA; Coen KM; Adamson KL; Chow BL
    Psychopharmacology (Berl); 1999 Feb; 141(4):428-35. PubMed ID: 10090651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist.
    Johnson PI; Stellar JR; Paul AD
    Neuropharmacology; 1993 Dec; 32(12):1305-14. PubMed ID: 8152522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors.
    Maldonado R; Feger J; Fournié-Zaluski MC; Roques BP
    Brain Res; 1990 Jun; 520(1-2):247-54. PubMed ID: 2169953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
    Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
    Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.